Cite
HARVARD Citation
Duvignaud, A. et al. (2022). Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE). Clinical microbiology and infection. pp. 1010-1016. [Online].